Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Liver toxicity of initial antiretroviral drug regimens including two nucleoside analogs plus one non-nucleoside analog or one ritonavir-boosted protease inhibitor in HIV/HCV-coinfected patients.

Macías J, Neukam K, Mallolas J, López-Cortés LF, Cartón JA, Domingo P, Moreno S, Iribarren JA, Clotet B, Crespo M, de Los Santos I, Ortega E, Knobel H, Jiménez-Expósito MJ, Pineda JA; COINS Study Team..

HIV Clin Trials. 2012 Mar-Apr;13(2):61-9. doi: 10.1310/hct1302-61.

PMID:
22510353
2.

Impact of reverse transcriptase resistance on the efficacy of TMC125 (etravirine) with two nucleoside reverse transcriptase inhibitors in protease inhibitor-naïve, nonnucleoside reverse transcriptase inhibitor-experienced patients: study TMC125-C227.

Ruxrungtham K, Pedro RJ, Latiff GH, Conradie F, Domingo P, Lupo S, Pumpradit W, Vingerhoets JH, Peeters M, Peeters I, Kakuda TN, De Smedt G, Woodfall B; TMC125-C227 study group..

HIV Med. 2008 Nov;9(10):883-96. doi: 10.1111/j.1468-1293.2008.00644.x.

3.

Cutaneous infection by Mycobacterium lentiflavum in a patient with HIV.

Montejo M, Goicoetxea J, Agesta N, Gil A, Urra E, Jimenez MS.

Dermatology. 2006;213(2):173-4. No abstract available.

PMID:
16902301
4.

Acute focal bacterial nephritis: report of four cases.

Montejo M, Santiago MJ, Aguirrebengoa K, Garcia B, Goicoetxea J, Martin A.

Nephron. 2002 Sep;92(1):213-5.

PMID:
12187105
5.

[Laryngeal tuberculosis: study of 11 cases].

Montejo M, Alonso M, Aguirrebengoa K, Moreno G, Goicoetxea J, Petreñas E, Bañuelos S, Vergez A.

Acta Otorrinolaringol Esp. 2001 Jan-Feb;52(1):53-6. Spanish.

Supplemental Content

Loading ...
Support Center